youtube_live
Q2 2027 earnings • released • EPS beat +4.58% • Revenue beat +3.65%
See resultschevron_right
HAE:NYSE
Haemonetics Corp
$119.93
arrow_downward
-3.37%(-4.18) 1D
$119.93
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:05 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
$121.16
High
$123.75
Low
$116.79
Mkt. cap
5.46B
Avg. vol.
724.52K
Volume
834.68K
P/E ratio
53.66
52-wk high
$128.82
52-wk low
$51.00
EPS
$2.24
Beta
0.63
Shares outstanding
45.50M
No. of employees
3K
Open
$121.16
High
$123.75
Low
$116.79
Mkt. cap
5.46B
Avg. vol.
724.52K
Volume
834.68K
P/E ratio
53.66
52-wk high
$128.82
52-wk low
$51.00
EPS
$2.24
Beta
0.63
Shares outstanding
45.50M
No. of employees
3K
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Haemonetics Q2 Earnings Call Highlights
Yahoo Finance
·
1 day ago
Haemonetics (HAE) Beats Q2 Expectations, Is The Stock Still Cheap?
The Globe and Mail
·
1 day ago
Bank of America Securities Reaffirms Their Buy Rating on Haemonetics (HAE)
Yahoo Finance
·
2 days ago
Haemonetics Corp (HAE) (Q2 2027) Earnings Call Highlights: Raised Guidance and Expanded CSL ...
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3.01K
Founded1971
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
IndustryMedical device
Websitehaemonetics.com